News: Morning Agenda: Pfizer’s War on Taxation
New Banking Rules for New York | Court Upholds Award Against RBC Capital | New Fed Rule Limits Emergency Lending
Read More…
Why Pfizer’s Deal May Change the System of Taxing Multinationals
The United States approach has been a failure, and a $ 152 billion drug merger could nudge tax-writing committees in Washington into action.